Showing results (2301-2310 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 24, 2012
Is an immune reaction required for malignant transformation and cancer growth?Richmond T Prehn, Liisa M Prehn
Cancer Immunology, Immunotherapy : CII|January 1, 1990
The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alphaM Scheringa, J N IJzermans, J Jeekel, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2012
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical studyRunmei Li, Changli Wang, Liang Liu, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Targeted immunotherapy of cancer with CAR T cells: achievements and challengesGrazyna Lipowska-Bhalla, David E Gilham, Robert E Hawkins, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancersKelly Barrios, Esteban Celis
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferationFeng Qian, Jianqun Liao, Jeannine Villella, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 2012
Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activityJorge Schettini, Amritha Kidiyoor, Dahlia M Besmer, et al.
Cancer Immunology, Immunotherapy : CII|May 8, 2012
Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapyAngela J Ziebarth, Mildred A Felder, Josephine Harter, et al.
Cancer Immunology, Immunotherapy : CII|May 8, 2012
Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypesInes Moeller, Giulio C Spagnoli, Jürgen Finke, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2012
FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancerPaul Salama, Colin Stewart, Cynthia Forrest, et al.
Pageof 652